phenotype
APOPTOSIS
Entity Detail — Knowledge Graph Node
Understanding Entity Pages
This page aggregates everything SciDEX knows about APOPTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
12353Connections
2Hypotheses
0Analyses
50Outgoing
50Incoming
1Experiments
0Debates
Summary
Apoptosis is programmed cell death essential for normal development and tissue homeostasis. In neurodegeneration, aberrant activation of apoptotic pathways contributes to neuronal loss. Key mediators include caspases, Bcl-2 family proteins, cytochrome c, and death receptors. Both intrinsic (mitochondrial) and extrinsic (death receptor) pathways are implicated in diseases like Alzheimer's, Parkinson's, and ALS.
AI-generated illustration
Regenerate portrait ↻Wiki Pages (1)
Knowledge base pages for this entity
Pathway Diagram
graph TD
subgraph Pathology["Pathology"]
APOPTOSIS["APOPTOSIS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| NLRP3["NLRP3"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| MICROGLIA["MICROGLIA"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| NEURON["NEURON"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| APP["APP"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| GFAP["GFAP"]
BECN1["BECN1"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
end
subgraph Signaling["Signaling"]
APOPTOSIS["APOPTOSIS"] -.->|"inhibits"| CANCER["CANCER"]
APOPTOSIS["APOPTOSIS"] -->|"activates"| Lymphoma["Lymphoma"]
APOPTOSIS["APOPTOSIS"] -->|"activates"| Apoptosis["Apoptosis"]
MITOPHAGY["MITOPHAGY"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| APOPTOSIS["APOPTOSIS"]
AKT["AKT"] -.->|"inhibits"| APOPTOSIS["APOPTOSIS"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
end
style APOPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CANCER fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Lymphoma fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style BECN1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0Outgoing (5311)
| Target | Relation | Type | Str |
|---|---|---|---|
| Lymphoma | therapeutic_target | disease | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Stroke | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Mitochondrial Function | activates | pathway | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| Apoptosis | interacts_with | pathway | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Cell Cycle | associated_with | pathway | 1.00 |
| Mapk | therapeutic_target | pathway | 1.00 |
| BCL2 | associated_with | gene | 1.00 |
| Leukemia | therapeutic_target | disease | 1.00 |
| Carcinoma | activates | disease | 1.00 |
| CANCER | inhibits | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Mtor | regulates | pathway | 1.00 |
| Als | regulates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| TNF | associated_with | gene | 1.00 |
| BCL-2 | associated_with | gene | 1.00 |
| FERROPTOSIS | associated_with | gene | 1.00 |
| Cardiovascular | activates | disease | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| Angiogenesis | regulates | pathway | 1.00 |
| INFLAMMATION | associated_with | gene | 1.00 |
| BAX | associated_with | gene | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| AUTOPHAGY | inhibits | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Leukemia | activates | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| AUTOPHAGY | targets | gene | 1.00 |
| PI3K | targets | gene | 1.00 |
| GENES | associated_with | gene | 1.00 |
| MTOR | targets | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| BCL-2 | regulates | gene | 1.00 |
Incoming (7042)
| Source | Relation | Type | Str |
|---|---|---|---|
| entities-ferroptosis | involved_in | wiki | 0.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| ATG7 | activates | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| Aging | associated_with | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| DNA | inhibits | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| OXIDATIVE STRESS | regulates | gene | 1.00 |
| ROS | inhibits | gene | 1.00 |
| Lung Cancer | therapeutic_target | disease | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| GENES | associated_with | gene | 1.00 |
| BCL-2 | therapeutic_target | gene | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| PARKINSON | therapeutic_target | gene | 1.00 |
| Inflammation | causes | disease | 1.00 |
| STROKE | therapeutic_target | gene | 1.00 |
| Senescence | activates | disease | 1.00 |
| MITOCHONDRIA | therapeutic_target | gene | 1.00 |
| IL-6 | activates | gene | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| EGFR | activates | gene | 1.00 |
| NF-ΚB | regulates | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 1.00 |
| MIRNAS | activates | gene | 1.00 |
| BAX | inhibits | gene | 1.00 |
| STROKE | activates | gene | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| EGFR | therapeutic_target | gene | 1.00 |
| NLRP3 | activates | gene | 1.00 |
| STAT3 | regulates | gene | 1.00 |
| MYC | activates | gene | 1.00 |
| STROKE | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | inhibits | gene | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| CYTOKINES | therapeutic_target | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | therapeutic_target | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| Breast Cancer | activates | disease | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| ERK | activates | gene | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| BECN1 | associated_with | gene | 1.00 |
| Als | activates | disease | 1.00 |
Targeting Hypotheses (2)
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Apoptosis-Senescence Decision Point Intervention | 0.649 | - | Senescent cell clearance as neurodegener |
| Colonic Th17/IL-17A Axis → Peripheral Immune Recruitment to | 0.640 | neurodegeneration | What are the mechanisms by which gut mic |
Mentioning Analyses (0)
Scientific analyses that reference this entity
No analyses mention this entity
Experiments (1)
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| dilncRNA-mediated molecular crowding and phase separation | exploratory | 0.900 | 0.00 | cultured cells | proposed | N/A |
Related Papers (1)
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Metformin and its potential influence on cell fate decision between apoptosis an [PMID:39267853] | ["Hajimohammadebrahim-Ketabforoush M", " | Front Oncol | 2024 | 0 |
Debates (0)
Multi-agent debates referencing this entity
No debates reference this entity
Related Research
Hypotheses and analyses mentioning APOPTOSIS in their description or question text
No additional research found